Healthlead Public Company Limited
Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, … Read more
Healthlead Public Company Limited (HL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.043x
Based on the latest financial reports, Healthlead Public Company Limited (HL) has a cash flow conversion efficiency ratio of 0.043x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿41.60 Million) by net assets (฿973.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Healthlead Public Company Limited - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Healthlead Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Healthlead Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Healthlead Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Emperor Entertainment Hotel Limited
F:EM7A
|
-0.006x |
|
Cleanspace Holdings Ltd
AU:CSX
|
0.133x |
|
Techbond Group Bhd
KLSE:5289
|
0.052x |
|
Alpha Microelectronics
TWO:8024
|
-0.018x |
|
Cogra 48 Société Anonyme
PA:ALCOG
|
0.147x |
|
IDP Corp Ltd.
KQ:332370
|
0.027x |
|
Thong Nhat Rubber JSC
VN:TNC
|
N/A |
|
Shui-Mu International Co Ltd
TW:8443
|
0.015x |
Annual Cash Flow Conversion Efficiency for Healthlead Public Company Limited (2018–2024)
The table below shows the annual cash flow conversion efficiency of Healthlead Public Company Limited from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ฿1.01 Billion | ฿88.76 Million | 0.088x | -6.40% |
| 2023-12-31 | ฿968.05 Million | ฿91.26 Million | 0.094x | -34.80% |
| 2022-12-31 | ฿941.99 Million | ฿136.20 Million | 0.145x | +46.98% |
| 2021-12-31 | ฿865.89 Million | ฿85.18 Million | 0.098x | -87.32% |
| 2020-12-31 | ฿124.97 Million | ฿96.96 Million | 0.776x | +4.14% |
| 2019-12-31 | ฿108.09 Million | ฿80.53 Million | 0.745x | +133.72% |
| 2018-12-31 | ฿86.33 Million | ฿27.52 Million | 0.319x | -- |